Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	166.06	21.14	7.95
Graham Fair Price	-66.71	25.47	76.49
PEG	2606.89	-0.38	0.01
Price/Book	-4.24	0.66	0.69
Price/Cash Flow	494.65	46.50	7.82
Prices/Earnings	795.58	33.44	3.73
Price/Sales	39.46	1.29	0.92
Price/FCF	494.65	46.50	7.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.97	0.45	0.42
Operating Margin	-78.88	0.02	0.10
ROA	-88.30	< 0.005	0.02
ROE	0.05	< 0.005	-89.31
ROIC	0.05	< 0.005	-86.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.39	0.29	35.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.29	-0.85	-62.85
EPS QOQ	2.69	-0.89	-66.91
FCF QOQ	1.99	-0.84	-58.00
Revenue QOQ	0.33	-0.30	-10.15
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	96.33	158.18	64.20
Days Sales Outstanding (DSO)	76.07	93.64	23.10
Inventory Turnover	0.93	0.57	-39.10
Debt/Capitalization	0.22	0.17	-23.25
Quick Ratio	1.15	1.06	-7.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	74.99	76.35	1.81
Cash	14.89	12.77	-14.23
Capex	-0.99	-0.70	29.37
Free Cash Flow	6.62	1.09	-83.61
Revenue	56.11	39.22	-30.10
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.83	1.91	4.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.35	1.54	13.54
Naive Interpretation	Member

06 - Financial Health · Weak

Rating